Login

Join Now

Life Sciences in Action

A Podcast Series by BioUtah

January 25, 2024
IP Discussion with Vera Nackovic of Mayer Brown »

BioUtah President & CEO Kelvyn Cullimore interviews Vera Nackovic, patent attorney for Mayer Brown to discuss intellectual property issues faced by life sciences companies. Vera Nackovic Bio A Registered Patent Attorney, Vera Nackovic advises clients on pharmaceutical, biologics, medical devices, nutraceuticals, and chemical patent matters—particularly intellectual property transactions, strategic development of global patent portfolios, and […]

December 13, 2023
Wilson Sonsini »

  BioUtah president & CEO Kelvyn Cullimore interviews Wilson Sonisini attorneys Meredith Krannich and Deno Himonas to discuss issues life sciences companies face when considering the need for legal counsel. Topics discussed include: Wilson Sonsini’s Executive Advisor Program to offer pro bono support and leadership to life sciences companies Development of In-house Counsel Dealing with […]

December 7, 2023
James McCullough, Renalytix »

BioUtah president & CEO Kelvyn Cullimore interviews Renalytix CEO James McCullough to discuss the growth, innovations of Renalytix, a diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Topics discussed include: Kidney diseases prognostics Working with the FDA to achieve regulatory hurdles Alternate means of […]

December 27, 2022
George O’Brien of Mayer Brown »

BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to legal issues life sciences companies face when dealing with the FDA.

February 1, 2021
James McCullough of RenalytixAI »

BioUtah president & CEO Kelvyn Cullimore interviews RenalytixAI CEO James McCullough to discuss the growth and innovations of RenalytixAI, a diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs.

January 5, 2021
Brad Brown of ATL Technology »

With a manufacturing facility in China, Utah-based ATL Technology was faced to deal with COVID months before the pandemic hit the United States. In this episode BioUtah’s president & CEO Kelvyn Cullimore interviews Brad Brown, CEO of ATL Technology discusses how their dealings with the pandemic in China helped them prepare for and deal with COVID-19’s impact on a life sciences company.